Home › Burkitt Lymphoma › New York › Greenburgh

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Greenburgh, NY

Isang pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Greenburgh. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

New York Medical College, Valhalla · 5 mi ang layo

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Nagre-recruitPhase 2

New York Medical College, Valhalla · 5 mi ang layo

365 Days · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

New York Medical College ( Site 1023), Valhalla · 5 mi ang layo

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3

New York Medical College, Valhalla · 5 mi ang layo

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

New York Medical College, Valhalla · 5 mi ang layo

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Nagre-recruitPhase 1/2

New York Medical Center, Valhalla · 5 mi ang layo

Edad 12 hanggang 70 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04491370

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Nagre-recruitPhase 2

New York Medical College, Valhalla · 5 mi ang layo

Edad 3 hanggang 31 · Lahat ng kasarian · Na-update Ago 8, 2025 · NCT02393157

Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Greenburgh

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.